SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing heightened volatility and intense trader interest as it joins the S&P 500 index, a move that is triggering mandatory institutional buying and significant market-making activity. The community remains sharply divided, with bulls pointing to the company's critical role in the AI optics supply chain and Nvidia's strategic investment, while bears warn of stretched valuations and risks stemming from shifting industry preferences toward copper technologies.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently under pressure as investors weigh recent reports of large-scale layoffs against concerns over massive AI infrastructure spending and looming legal challenges. Community sentiment is sharply divided between long-term believers citing the company's valuation and dominant advertising position, and skeptical traders who view recent price action as a technical breakdown signaling further downside risk.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is facing significant volatility as investors debate the viability of the company's turnaround plan, balancing recent traffic improvements against margin pressures and intense competition from faster, value-oriented rivals. The community remains deeply divided, with some betting on a long-term recovery under new leadership while others highlight declining brand loyalty and store closures as indicators of structural trouble.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is experiencing intense downward pressure as institutional investors and the trading community grapple with a broader sector rotation away from software and cybersecurity, exacerbated by speculative concerns regarding the impact of new AI-driven coding tools. While bullish investors argue the sell-off is a fundamental decoupling and a prime buying opportunity for a SASE leader, the stock faces consistent technical selling and heightened short interest from those betting on continued valuation compression.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth Inc is seeing significant volatility as investors debate the impact of potential federal funding scrutiny and legal challenges surrounding the company's IP and leadership. Despite the uncertainty, the community remains heavily focused on the stock's role in domestic supply chain security, with many traders accumulating shares during the dip in anticipation of production updates.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Walt Disney Co. is in the spotlight as investors react to the appointment of Parks chief Josh D'Amaro as the new CEO, succeeding Bob Iger in a move aimed at revitalizing long-term stock performance. While the community is actively debating the company's future strategy, leadership transition, and ongoing cost-cutting efforts, sentiment remains mixed between those seeking a turnaround and skeptics wary of the stock's recent performance.

OpenAI pioneers large-language models like GPT and DALL·E, enabling advanced AI applications. Their research emphasizes both cutting-edge capability and responsible deployment strategies.

OpenAI PreStocks

Community sentiment regarding OpenAI is heavily polarized, with active discussions focusing on both its leadership in AI traffic and the rise of speculative, unofficial crypto assets claiming to provide investment exposure. Investors are also scrutinizing the company's massive capital expenditure requirements and the potential long-term impact of its partnerships on the financial health of major corporate collaborators.

Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International, and Foodservice. The Grocery and Snacks segment includes branded, and shelf stable food products sold in various retail channels in the United States. The Refrigerated and Frozen segment is composed of branded, and temperature-controlled food products sold in various retail channels in the United States. The International segment offers branded food products in various temperature states, sold in various retail and foodservice channels outside of the United States. The Foodservice segment focuses on branded and customized food products, including meals, entrees, sauces, and a variety of custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The company was founded by Alva Kinney and Frank Little in 1919 and is headquartered in Chicago, IL.

Conagra Brands Inc

Conagra Brands is currently a focal point for investors weighing its high dividend yield and valuation as a potential defensive anchor against market volatility, despite ongoing concerns regarding operational pressures, input costs, and debt levels. The community is actively debating whether the stocks current price reflects a generational buying opportunity for a long-term value play or a value trap amid broader sector headwinds.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. (CNC) is capturing attention as traders monitor potential legislative updates regarding Affordable Care Act subsidy extensions, fueling debates over the stock's future valuation and regulatory sensitivity. Meanwhile, technical analysts and active traders are focused on identifying support levels and momentum signals amidst broader sector volatility and mixed institutional positioning.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors debate the impact of AI on enterprise software, with the stock recently seeing significant insider buying from the CEO and aggressive share buybacks. Community discussion centers on whether the stock is a long-term value opportunity at current levels or if AI fears and seat-based revenue compression will continue to pressure the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tenon Medical (TNON) Q4 2025 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

WallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 Million

WallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 Million WallachBeth Capital...

Shares of Tenon Medical, Inc. surged more than 280% on Tuesday, marking their best day ever, with the nano-cap medical device firm's retail following&nbsp;on Stocktwits surging the most among healthcare stocks after a key regulatory approval.During after-hours trading on Monday, Tenon said that the U.S. Food and Drug Administration had cleared its Catamaran SI Joint Fusion System for expanded use in augmenting thoracolumbar fusion."With this approval, the Catamaran is now indicated to treat the SI [sacroiliac] joint as either a stand-alone treatment or to augment a spinal fusion," the company said in a statement.Tenon's Catamaran system is designed as a minimally invasive solution for stabilizing the joint where the lower spine and pelvic bone meet. It uses a single titanium implant to secure the joint by passing through key bone structures.&nbsp;On Stocktwits, Tenon gained 25% more followers from a day ago, as sentiment turned even more 'extremely bullish' while message volume soared by 813%.One user said if the stock breaks the $5 level again, it "will go to $7+ fast. Shorts will have to cover."<stembedurl>https://stocktwits.com/BullsEye2000/message/609170603</stembedurl>However, Tenon shares fell more than 5% in Tuesday's extended trading after the company announced a $1.5 million registered direct offering to a healthcare-focused institutional investor.&nbsp;Under the agreement, Tenon will issue 733,500 shares at $2 each and an equal number of warrants exercisable at the same price.&nbsp;The company expects to close the offering on Wednesday, and the proceeds will be used for working capital and general corporate purposes.However, several optimistic retail watchers were still not rankled. One user said, "Everyone's panicking over the offering, but it was a direct offering so it got them secured cash to move forward without diluting the base rapidly."<stembedurl>https://stocktwits.com/FLCaptain/message/609231053</stembedurl>Tenon's stock has gained a whopping 93% so far this year. The sole analyst covering it on Wall Street rates it a 'strong buy,' according to Koyfin.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tenon Medical Stock Rockets Nearly 4x, Leads Retail Follower Surge In Healthcare: What's Driving The Hype?

The medical device company said that the FDA had cleared its Catamaran SI Joint Fusion System for expanded use in augmenting thoracolumbar fusion.

Equity

Shares of surgical solutions firm Tenon Medical, Inc (TNON) shot up over 145% on Friday after the company announced the pricing of its public offering of shares and warrants in order to meet a Nasdaq minimum float requirement.The firm had earlier received a letter from Nasdaq stating that it did not meet the “minimum 500,000 publicly held shares requirement.”&nbsp;The compliance issue followed Tenon Medical common stock’s 1-for-8 reverse split which reduced the firm’s outstanding common stock from a little over 4.08 million shares to 510,221 shares outstanding on a post-reverse split basis. Only 490,364 of such shares qualified as publicly held shares for purposes of the minimum float requirement, the firm said in an SEC filing.Nasdaq had provided time till October 24, 2024 for the firm to come up with a plan to regain the compliance. Tenon, however, stated that it expects to regain compliance with the minimum float requirement in September itself.On Friday, the company announced the pricing of its "reasonable best efforts" public offering with a single health-care focused institutional investor for the purchase and sale of up to 1,222,850 shares of common stock and warrants to purchase an equal number of shares at a combined offering price of $3.68 per share.Tenon expects to receive aggregate gross proceeds of approximately $4.5 million, assuming no exercise of the warrants. The firm said that the warrants will have an exercise price of $3.55 per share and will be exercisable immediately. They will expire five years from the issuance date, Tenon said.The offering is expected to close on Sept. 16, 2024, with Tenon intending to use the net proceeds for commercial activity, working capital and general corporate purposes.In early September, the firm entered into a securities purchase agreement with certain investors to offer a total of 86,454 Series B preferred stock and warrants to purchase 16,214 shares of common stock at an exercise price equal to $4.2756 per share for an aggregate offering price of $550,000.Tenon Medical’s shares have gained more than 87% over the last month, with the firm attracting investor eyeballs in the wake of the compliance developments.&nbsp;As a result, Stocktwits message volume shot up a whopping 64,900% during the same period as investors continued to discuss the fate of the stock.Some investors, however, are advising to maintain caution.<stembedurl>https://stocktwits.com/Spacerobot/message/585993209</stembedurl>Also See: <a href="https://stocktwits.com/news/markets/equity/united-airlines-to-offer-free-inflight-wifi-using-spacexs-starlink/c7zC6s5R5e">United Airlines To Offer Free Inflight Wi-Fi From SpaceX’s Starlink: Retail Sentiment Gets A Boost</a>

Nasdaq had provided time till October 24, 2024 for Tenon Medical to come up with a plan to regain the compliance.

Tenon Stock Skyrockets 145% After Public Offering To Meet Nasdaq Rules: Retail Chatter Goes Through The Roof

The firm had earlier received a letter from Nasdaq stating that it did not meet the “minimum 500,000 publicly held shares requirement.”

$TNON Q4 &#39;25 Earnings Results &amp; Recap

Tenon Medical reported Q4 2025 revenue of $1.5M, a 92% increase, and full year revenue of $3.9M, up 20%. Gross margin improved to 69% in Q4 and 60% for FY2025.

Stocktwits

Tenon Medical Inc

 Q4 '25 Earnings Results & Recap

Tenon Medical reported Q4 2025 revenue of $1.5M, a 92% increase, and full year revenue of $3.9M, up 20%. Gross margin improved to 69% in Q4 and 60% for FY2025.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.

Current Price	$0.8026
Prev Close	$0.835
Open	$0.80
Dividend Yield	0.00%
50-Day Moving Average	$0.8437
Beta	0.82
Avg. Volume	3.03M
PE Ratio	-0.39

52-Week High	$5.85
52-Week Low	$0.641
Market Capitalization	$8.91M
EPS (Annual)	-$1.70
Price to Book	4.43
Revenue Per Employee	$146,074.07

TNON
Tenon Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TNON News

TNONTenon Medical Inc